Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.87 HKD | +2.19% |
|
-2.63% | -6.53% |
May. 08 | Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma | MT |
Apr. 09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Anti-viral Drugs
88.7
%
| 3,624 | 83.2 % | 6,166 | 88.7 % | +70.17% |
Other Medical Products
4.1
%
| 323 | 7.4 % | 286 | 4.1 % | -11.54% |
Cardiovascular Drugs
2.9
%
| 175 | 4.0 % | 203 | 2.9 % | +16.55% |
Endocrine and Metabolic Drugs
2.6
%
| 132 | 3.0 % | 181 | 2.6 % | +37.45% |
Anti-infectives Drugs
1.7
%
| 101 | 2.3 % | 118 | 1.7 % | +16.52% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 4,355 | 100.0 % | 6,956 | 100.0 % | +59.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Cai Jiang
CEO | Chief Executive Officer | 42 | 15-05-03 |
Qiang Zhang
DFI | Director of Finance/CFO | 49 | 18-02-22 |
Hao Chen
BRD | Director/Board Member | 49 | 09-10-31 |
Shuang Li
BRD | Director/Board Member | 43 | 05-08-06 |
Dan Jin Wang
BRD | Director/Board Member | 54 | 06-02-26 |
Qi Yun Peng
IRC | Investor Relations Contact | 34 | 16-06-30 |
Wai Chiu Wong
SEC | Corporate Secretary | 69 | 22-02-24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jian Xin Tang
BRD | Director/Board Member | 59 | 15-05-03 |
Xin Fa Tang
CHM | Chairman | 54 | 15-05-03 |
Dan Jin Wang
BRD | Director/Board Member | 54 | 06-02-26 |
Zhong Hua Luo
BRD | Director/Board Member | 40 | 17-06-15 |
Shuang Li
BRD | Director/Board Member | 43 | 05-08-06 |
Sheng Chao Wang
BRD | Director/Board Member | 41 | 12-04-30 |
Jin Long Tang
CHM | Chairman | 55 | 01-06-30 |
Ling Xiang
BRD | Director/Board Member | 43 | 20-06-04 |
Xue Chen Li
BRD | Director/Board Member | 47 | 20-09-24 |
Hao Chen
BRD | Director/Board Member | 49 | 09-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 226,200,000 | 0 | 0 | 27.70 % |
Stock B | 1 | 653,767,700 | 243,709,300 ( 37.28 %) | 0 |
Company contact information
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
No. 38, Binjiang Road Yidu
443300, Yichang
+
http://cj.hec.cn/en/index.aspx![address YiChang HEC ChangJiang Pharmaceutical Co., Ltd.(1558)](https://cdn.zonebourse.com/static/address/25502714.png)
Sector
Sales per Business
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.53% | 978M | |
+59.21% | 846B | |
+38.56% | 628B | |
-4.71% | 360B | |
+17.71% | 322B | |
+9.24% | 297B | |
+14.15% | 240B | |
+3.11% | 224B | |
+16.98% | 223B | |
+12.87% | 173B |
- Stock Market
- Equities
- 1558 Stock
- Company YiChang HEC ChangJiang Pharmaceutical Co., Ltd.